Estrogen receptors alpha and beta in bone

Bone

Volumn 87, Issue , 2016, Pages 130-135

  Khalid, Aysha B ^a   Krum, Susan A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bone; Estrogen; Estrogen receptor alpha (ER , ESR1); Estrogen receptor beta (ER , ESR2)

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BONE DENSITY; BONE METABOLISM; CELLS BY BODY ANATOMY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; RECEPTOR BINDING; REVIEW; TRABECULAR BONE; ANIMAL; BONE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM;

ANIMALS; BONE AND BONES; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION; HUMANS; OSTEOBLASTS; OSTEOCLASTS;

EID: 84963585089     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2016.03.016     Document Type: Review

References (83)

1. Wend K., Wend P., Krum S.A. Tissue-specific effects of loss of estrogen during menopause and aging. Front Endocrinol. (Lausanne) 2012, 3:19.
2. Candelaria N.R., Liu K., Lin C.Y. Estrogen receptor alpha: molecular mechanisms and emerging insights. J. Cell. Biochem. 2013, 114(10):2203-2208.
3. Gorski J., et al. Hormone receptors: studies on the interaction of estrogen with the uterus. Recent Prog. Horm. Res. 1968, 24:45-80.
4. Green S., et al. Cloning of the human oestrogen receptor cDNA. J. Steroid Biochem. 1986, 24(1):77-83.
5. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(12):5925-5930.
6. Krum S.A., Brown M. Unraveling estrogen action in osteoporosis. Cell Cycle 2008, 7(10):1348-1352.
7. Krum S.A. Direct transcriptional targets of sex steroid hormones in bone. J. Cell. Biochem. 2011, 112(2):401-408.
8. Khosla S. Update on estrogens and the skeleton. J. Clin. Endocrinol. Metab. 2010, 95(8):3569-3577.
9. Manolagas S.C., O'Brien C.A., Almeida M. The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol. 2013, 9(12):699-712.
10. Vanderschueren D., Laurent M.R., Claessens F., Gielen E., Lagerquist M.K., Vandenput L., Börjesson A.E., Ohlsson C. Sex steroid actions in male bone. Endocr Rev. 2014, 35(6):906-960.
11. Williams C., et al. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells. Oncogene 2008, 27(7):1019-1032.
12. Nelson A.W., et al. Estrogen receptor beta in prostate cancer: friend or foe?. Endocr. Relat. Cancer 2014, 21(4):T219-T234.
13. Ogawa S., et al. Survival of reproductive behaviors in estrogen receptor beta gene-deficient (betaERKO) male and female mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96(22):12887-12892.
14. Paech K., et al. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277(5331):1508-1510.
15. Cauley J.A. Estrogen and bone health in men and women. Steroids 2015, 99(Pt A):11-15.
16. Rossouw J.E., et al. Risks and benefits of estrogen plus progestin in healthy postLindberg, et al.: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.
17. Pacifici R., et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(7):2398-2402.
18. Jilka R.L., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257(5066):88-91.
19. Weitzmann M.N., et al. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J. Clin. Invest. 2002, 110(11):1643-1650.
20. Krum S.A., et al. Novel functions for NFkappaB: inhibition of bone formation. Nat. Rev. Rheumatol. 2010, 6(10):607-611.
21. Kameda T., et al. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 1997, 186(4):489-495.
22. Kousteni S., et al. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002, 298(5594):843-846.
23. Garcia A.J., et al. ERalpha signaling regulates MMP3 expression to induce FasL cleavage and osteoclast apoptosis. J. Bone Miner. Res. 2013, 28(2):283-290.
24. Krum S.A., et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 2008, 27(3):535-545.
25. Bord S., et al. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003, 32(2):136-141.
26. Martin A., et al. Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association. Bone 2015, 75:96-104.
27. Kousteni S., et al. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 2001, 104(5):719-730.
28. Pantschenko A.G., et al. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J. Bone Miner. Res. 2005, 20(8):1414-1429.
29. Krum S.A., et al. Unique ER{alpha} cistromes control cell type-specific gene regulation. Mol. Endocrinol. 2008.
30. Bord S., et al. Estrogen receptors alpha and beta are differentially expressed in developing human bone. J. Clin. Endocrinol. Metab. 2001, 86(5):2309-2314.
31. Braidman I.P., et al. Localization of estrogen receptor beta protein expression in adult human bone. J. Bone Miner. Res. 2001, 16(2):214-220.
32. Crusode de Souza M., Sasso-Cerri E., Cerri P.S. Immunohistochemical detection of estrogen receptor beta in alveolar bone cells of estradiol-treated female rats: possible direct action of estrogen on osteoclast life span. J. Anat. 2009, 215(6):673-681.
33. Harkonen P.L., Vaananen H.K. Monocyte-macrophage system as a target for estrogen and selective estrogen receptor modulators. Ann. N. Y. Acad. Sci. 2006, 1089:218-227.
34. Pacifici R. Estrogen deficiency, T cells and bone loss. Cell. Immunol. 2008, 252(1-2):68-80.
35. Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell. Immunol. 2015, 294(2):63-69.
36. Gennari L., et al. Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol. 2005, 161(4):307-320.
37. Estrada K., et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat. Genet. 2012, 44(5):491-501.
38. Paternoster L., et al. Genetic determinants of trabecular and cortical volumetric bone mineral densities and bone microstructure. PLoS Genet. 2013, 9(2):e1003247.
39. Smith E.P., et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331(16):1056-1061.
40. Couse J.F., et al. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 1995, 9(11):1441-1454.
41. Dupont S., et al. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000, 127(19):4277-4291.
42. Sims N.A., et al. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 2002, 30(1):18-25.
43. Krege J.H., et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(26):15677-15682.
44. Windahl S.H., et al. Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J. Clin. Invest. 1999, 104(7):895-901.
45. Windahl S.H., et al. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss. J. Bone Miner. Res. 2001, 16(8):1388-1398.
46. Antal M.C., et al. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ERbeta-null mutant. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(7):2433-2438.
47. Vidal O., et al. Disproportional body growth in female estrogen receptor-alpha-inactivated mice. Biochem. Biophys. Res. Commun. 1999, 265(2):569-571.
48. Saxon L.K., et al. Estrogen receptors alpha and beta have different gender-dependent effects on the adaptive responses to load bearing in cancellous and cortical bone. Endocrinology 2012, 153(5):2254-2266.
49. Galea G.L., et al. Estrogen receptor alpha mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor beta. J. Biol. Chem. 2013, 288(13):9035-9048.
50. Saxon L.K., et al. The skeletal responsiveness to mechanical loading is enhanced in mice with a null mutation in estrogen receptor-beta. Am. J. Physiol. Endocrinol. Metab. 2007, 293(2):E484-E491.
51. Lee K.C., et al. The adaptive response of bone to mechanical loading in female transgenic mice is deficient in the absence of oestrogen receptor-alpha and -beta. J. Endocrinol. 2004, 182(2):193-201.
52. Sims N.A., et al. A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J. Clin. Invest. 2003, 111(9):1319-1327.
53. Windahl S.H., Andersson G., Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 2002, 13(5):195-200.
54. vanKoevering K.K., Williams B.O. Transgenic mouse strains for conditional gene deletion during skeletal development. IBMS BoneKEy 2008, 5(5):151-170.
55. Kim S.W., et al. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J. Bone Miner. Res. 2012, 27(10):2075-2084.
56. Almeida M., et al. Estrogen receptor-alpha signaling in osteoblast progenitors stimulates cortical bone accrual. J. Clin. Invest. 2013, 123(1):394-404.
57. Maatta J.A., et al. Inactivation of estrogen receptor alpha in bone-forming cells induces bone loss in female mice. FASEB J. 2013, 27(2):478-488.
58. Melville K.M., et al. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J. Bone Miner. Res. 2014, 29(2):370-379.
59. Windahl S.H., et al. Estrogen receptor-alpha in osteocytes is important for trabecular bone formation in male mice. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(6):2294-2299.
60. Martin-Millan M., et al. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol. Endocrinol. 2010, 24(2):323-334.
61. Syed F.A., et al. Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J. Bone Miner. Res. 2005, 20(11):1992-2001.
62. Ikeda K., et al. Conditional expression of constitutively active estrogen receptor alpha in osteoblasts increases bone mineral density in mice. FEBS Lett. 2011, 585(9):1303-1309.
63. Pedram A., et al. Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse. J. Biol. Chem. 2009, 284(6):3488-3495.
64. Pedram A., et al. Membrane and nuclear estrogen receptor alpha collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 2016, 30(1):230-240.
65. Borjesson A.E., et al. The role of activation functions 1 and 2 of estrogen receptor-alpha for the effects of estradiol and selective estrogen receptor modulators in male mice. J. Bone Miner. Res. 2013, 28(5):1117-1126.
66. Ohlsson C., et al. Estrogen receptor-alpha expression in neuronal cells affects bone mass. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(3):983-988.
67. Mendez-Ferrer S., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466(7308):829-834.
68. Cornish J., et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol. 2002, 175(2):405-415.
69. Thomas T., et al. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140(4):1630-1638.
70. Williams G.A., et al. Skeletal phenotype of the leptin receptor-deficient db/db mouse. J. Bone Miner. Res. 2011, 26(8):1698-1709.
71. Henning P., et al. The effect of estrogen on bone requires ERalpha in nonhematopoietic cells but is enhanced by ERalpha in hematopoietic cells. Am. J. Physiol. Endocrinol. Metab. 2014, 307(7):E589-E595.
72. Nicks K.M., et al. Deletion of estrogen receptor beta in osteoprogenitor cells increases trabecular but not cortical bone mass in female mice. J. Bone Miner. Res. 2016, 31(3):606-614.
73. Roforth M.M., et al. Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing. PLoS One 2014, 9(4):e95987.
74. Parikka V., et al. Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur. J. Endocrinol. 2005, 152(2):301-314.
75. Kuiper G.G., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139(10):4252-4263.
76. Ricci E., et al. Soy isoflavones and bone mineral density in perimenopausal and postmenopausal Western women: a systematic review and meta-analysis of randomized controlled trials. J. Womens Health (Larchmt) 2010, 19(9):1609-1617.
77. Turner R.T., et al. Genistein administered as a once-daily oral supplement had no beneficial effect on the tibia in rat models for postmenopausal bone loss. Menopause 2013, 20(6):677-686.
78. Picherit C., et al. Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. J. Nutr. 2000, 130(7):1675-1681.
79. Harris H.A., et al. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003, 144(10):4241-4249.
80. Monroe D.G., et al. Estrogen receptor isoform-specific regulation of endogenous gene expression in human osteoblastic cell lines expressing either ERalpha or ERbeta. J. Cell. Biochem. 2003, 90(2):315-326.
81. Monroe D.G., et al. Estrogen receptor isoform-specific regulation of the retinoblastoma-binding protein 1 (RBBP1) gene: roles of AF1 and enhancer elements. J. Biol. Chem. 2006, 281(39):28596-28604.
82. Monroe D.G., et al. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Mol. Endocrinol. 2005, 19(6):1555-1568.
83. Lindberg M.K., et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol. Endocrinol. 2003, 17(2):203-208.